Highlights in Lung Cancer, 2013, Part 5: Maintenance Therapy in Advanced NSCLC (video)

Highlights in Lung Cancer, 2013, Part 5: Maintenance Therapy in Advanced NSCLC (video)

Desde: GRACEcast
0 0 hace 7 años
Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, summarizes evidence from the PARAMOUNT trial, demonstrating a survival benefit for continuation maintenance therapy with Alimta (Pemetrexed) in advanced non-small cell lung cancer.

Síguenos en Facebook